Subcutaneous Selatogrel Inhibits Platelet Aggregation in Patients With Acute Myocardial Infarction.

Volume: 75, Issue: 20, Pages: 2588 - 2597
Published: May 26, 2020
Abstract
null null Background null Oral P2Y12 receptor antagonists exhibit delayed onset of platelet inhibition in patients with acute myocardial infarction (AMI). Selatogrel is a potent, highly selective, and reversible P2Y12 receptor antagonist with a rapid onset and short duration of action. null null null Objectives null This study sought to assess inhibition of platelet aggregation following subcutaneous administration of selatogrel in patients with...
Paper Details
Title
Subcutaneous Selatogrel Inhibits Platelet Aggregation in Patients With Acute Myocardial Infarction.
Published Date
May 26, 2020
Volume
75
Issue
20
Pages
2588 - 2597
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.